Search results
Results From The WOW.Com Content Network
An Australian Approved Name (AAN) is a generic drug name set by the Therapeutic Goods Administration (TGA) for use in Australia. [1] In late 2016, the TGA changed several drug names to the corresponding international nonproprietary name (INN), or, in cases where an INN was not available (as with asparaginase), another established generic name, such as the United States Adopted Name (USAN).
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. [4] As part of the Department of Health and Aged Care, the TGA regulates the safety, quality, efficacy and advertising in Australia of therapeutic goods (which comprise medicines, medical devices, biologicals and certain other therapeutic goods).
D11567. Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes to improve glycemic control in combination with diet and exercise. [7][8] It contains insulin degludec and liraglutide. [7][8] It is administered by subcutaneous injection. [7][8] The ...
Schedule 9 (S9) drugs and poisons are substances and preparations that, by law, may only be used for research purposes. The sale, distribution, use, and manufacture of such substances without a permit is strictly prohibited by law. Permits for research uses on humans must be approved by a recognised ethics committee on human research. Examples ...
Risdiplam. Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) [ 6 ][ 9 ] and the first oral medication approved to treat this disease. [ 6 ][ 9 ] Risdiplam is a survival of motor neuron 2 -directed RNA splicing modifier. [ 6 ][ 5 ][ 10 ]
Etifoxine is the generic name of the drug and its INN Tooltip International Nonproprietary Name, BAN Tooltip British Approved Name, and DCF Tooltip Dénomination Commune Française. [ 30 ] [ 31 ] It is also known by the older and much-lesser-used synonym etafenoxine [ 40 ] and by its developmental code name Hoe 36801 .
Sorafenib, sold under the brand name Nexavar, [3] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Vosoritide. Vosoritide, sold under the brand name Voxzogo, is a medication used for the treatment of achondroplasia, [3][4][5] a genetic condition that causes severely short stature and disproportionate growth. [4] Achondroplasia is caused by a genetic mutation that increases the activity of a certain growth regulation gene called fibroblast ...